Researchers used digital polymerase chain reaction assays to measure BRAF V600E or BRAF V600K circulating tumor DNA in ...

Monitoring circulating tumor DNA levels before and during treatment may predict melanoma recurrence, offering a potential ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

Researchers showed that approximately 80 percent of stage 3 melanoma patients who had detectable levels of circulating tumor ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...

DNA fragments found in the bloodstream during treatment could mean that a patient’s cancer is getting worse, researchers said ...

This tumor DNA, also known as circulating tumor DNA (ctDNA), is released by cancer cells into the bloodstream. Tracking ctDNA ...

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following ...